Tech Company Financing Transactions
FoldRx Pharmaceuticals Funding Round
On 5/31/2006, FoldRx Pharmaceuticals raised $43 million in Series B financing from Alta Partners, TPG Capital and F-Prime Capital.
Transaction Overview
Company Name
Announced On
5/31/2006
Transaction Type
Venture Equity
Amount
$43,000,000
Round
Series B
Investors
Alta Partners (Lead Investor)
TPG Capital (Lead Investor)
Proceeds Purpose
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
100 Acorn Park Drive 5th Floor
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Website
Email Address
Overview
FoldRx is a leader in the discovery and development of first in class disease modifying drug therapies for diseases of protein misfolding and amyloidosis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Labaudiniere
Chief Medical Officer
Donna Grogan
Vice President
Bill Aliski
Vice President
Jeff Packman
Browse more venture capital transactions:
Prev: 5/30/2006: Complete Genomics venture capital transaction
Next: 5/31/2006: Profectus BioSciences venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs